May 03, 2019
4 min watch
Save

VIDEO: Eyenovia progressing in mydriasis, glaucoma, myopia treatments

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN DIEGO At the Ophthalmology Innovation Summit, Sean Ianchulev, MD, MPH, CEO of Eyenovia, discusses the company’s technology in development for mydriasis, as well as glaucoma and myopia treatments.